Northwestern Mutual Wealth Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-242
Closed 2774
2019
Q3
$0 Hold
242
﹤0.01% 2826
2019
Q2
$0 Hold
242
﹤0.01% 2843
2019
Q1
$0 Hold
242
﹤0.01% 2806
2018
Q4
$0 Hold
242
﹤0.01% 2801
2018
Q3
$0 Hold
242
﹤0.01% 2779
2018
Q2
$0 Hold
242
﹤0.01% 2585
2018
Q1
$0 Hold
242
﹤0.01% 2559
2017
Q4
$0 Hold
242
﹤0.01% 2555
2017
Q3
$0 Hold
242
﹤0.01% 2382
2017
Q2
$0 Hold
242
﹤0.01% 2284
2017
Q1
$0 Hold
242
﹤0.01% 2666
2016
Q4
$0 Buy
+242
New +$272 ﹤0.01% 2419
2016
Q3
Sell
-242
Closed 1999
2016
Q2
$0 Buy
+242
New +$312 ﹤0.01% 2413
2013
Q3
Sell
-56
Closed 1592
2013
Q2
$0 Buy
+56
New +$406 ﹤0.01% 1278

Northwestern Mutual Wealth Management's CELGZ Position: Q4 2019 in Review

Northwestern Mutual Wealth Management sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 242 shares.

Northwestern Mutual Wealth Management first reported a position in CELGZ in Q2 2013 and held it in 14 quarters. The position peaked at $0 in Q3 2019. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

  • Northwestern Mutual Wealth Management reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 242 Celgene Corporation Contingent Value Rights shares in Q4 2019.
  • Northwestern Mutual Wealth Management first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 14 quarters.
  • Northwestern Mutual Wealth Management's Celgene Corporation Contingent Value Rights position peaked at $0 in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2019, filed 13 Feb 2020.